NOTCH1 and Merkel cell skin cancer: Further analyses revealed that GP-2250 could downregulate Notch1 in a time- and dose-dependent manner in at least two out of three MCC cell lines, indicating that inhibition of the Notch pathway might aid in attenuating MCC [60].